FindTrial
Sign In

Rituximab (Arm A)

DRUG3 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Angelica Lindén Hirschberg, Yang Donglin

Conditions

Allogeneic Hematopoietic Stem Cell TransplantationAutoimmune Prematur Ovarian InsuffienceClinically Significant EBV DNAemiaEpstein-Barr Virus ReactivationGranulomatosis With PolyangiitisMicroscopic PolyangiitisRenal Limited Forms

Phase 3

Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
CompletedNCT01731561
Assistance Publique - Hôpitaux de ParisGranulomatosis With Polyangiitis, Microscopic Polyangiitis, Renal Limited Forms
Start: 2012-11-16End: 2016-04-05Updated: 2025-09-05
Immunomodulatory Therapy to Restore Ovarian Function and Improve Fertility in Women With Autoimmune Premature Ovarian Insufficiency
RecruitingNCT07509840
Angelica Lindén HirschbergAutoimmune Prematur Ovarian Insuffience
Start: 2026-02-12End: 2031-12-31Target: 40Updated: 2026-04-03

Unknown Phase

A Randomized Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation
Not yet recruitingNCT07703657
Yang DonglinAllogeneic Hematopoietic Stem Cell Transplantation, Clinically Significant EBV DNAemia, Epstein-Barr Virus Reactivation
Start: 2026-07-09End: 2027-07-09Target: 168Updated: 2026-07-14

Related Papers

Association Between Plasma Rituximab Concentration and the Risk of Major Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides During Rituximab Maintenance Therapy
Arthritis & Rheumatology2023-05-039 citations
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).
2018-04-25209 citations